Tripterygium wilfordii

Tripterygium wilfordii contains active compounds, primarily triptolide and celastrol, that exert anti-inflammatory effects through multiple pathways. These compounds inhibit nuclear factor-kappa B (NF-κB) signaling, suppress pro-inflammatory cytokines like TNF-alpha and interleukin-6, and reduce T-cell proliferation. Additionally, they inhibit cyclooxygenase-2 (COX-2) expression. This multi-target mechanism makes the herb potentially effective for autoimmune conditions, though evidence remains at Level C, requiring more rigorous human clinical trials to fully establish efficacy.

No, Tripterygium wilfordii should not be combined with immunosuppressant medications. This herb possesses potent immunosuppressive properties, and combining it with drugs like methotrexate, cyclosporine, or corticosteroids may cause excessive immune suppression, significantly increasing infection risk. Additionally, Tripterygium wilfordii can cause bone marrow suppression and renal toxicity, effects that may compound similar side effects from conventional immunosuppressants. Patients should always consult a qualified healthcare provider before combining this herb with any prescription medications.

There is no established safe over-the-counter dosage for Tripterygium wilfordii due to its narrow therapeutic window and significant toxicity risks. In clinical settings, extracts standardized to triptolide content are used strictly under medical supervision, typically starting at very low doses with careful titration. Traditional Chinese medicine preparations vary considerably in potency. Self-medication is strongly discouraged given the risk of serious adverse effects. This herb should only be used under guidance of a qualified healthcare practitioner experienced with its toxicity profile.

No, Tripterygium wilfordii is absolutely contraindicated during pregnancy and breastfeeding. The herb contains triptolide and related compounds that are highly toxic and can cause fetal harm, miscarriage, and birth defects. Animal studies have demonstrated clear teratogenic effects. These toxic compounds can also pass into breast milk, making breastfeeding unsafe while taking this herb. Women of childbearing age should use reliable contraception during treatment. If pregnancy occurs while taking Tripterygium wilfordii, discontinue immediately and consult a healthcare provider.

Tripterygium wilfordii carries significant toxicity risks that limit its use. Serious side effects include male infertility through reduced sperm production, which may be irreversible after prolonged use. Bone marrow suppression can lead to decreased blood cell counts, increasing infection and bleeding risks. Gastrointestinal toxicity includes nausea, vomiting, and diarrhea. Cardiac toxicity and renal impairment have also been reported. The therapeutic window is narrow, meaning effective doses approach toxic levels. This herb should only be used under qualified medical supervision with regular monitoring of blood counts, kidney function, and cardiac status.